Altria Profit and Margin by Product Segment

Cigar and whisky. Pixabay Image.

This article presents Altria Group’s profits and margins by product category.

Altria’s product segments consist of two major categories: smokeable products and oral tobacco products. Their definitions are available in this section: Altria’s segments.

Altria’s wine product segment was divested in fiscal year 2021 and is no longer reported as a segment.

Let’s take a look!

For other key statistics of Altria, you may find more resources on this page: Altria key stats.

Please use the table of contents to navigate this page.

Definitions

To help readers understand the content better, the following terms and glossaries have been provided.

Segment Operating Companies Income (OCI): Altria’s segment operating companies income (OCI) is a non-GAAP measure created to evaluate the performance and allocation of resources to a business segment by the management.

According to Altria, segment operating companies income (OCI) is defined as operating income before general corporate expenses and amortization of intangibles.

Altria said that its interest and other debt expense, net, along with net periodic benefit income, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the management.

Smokeable Products Segment: Altria’s smokeable tobacco products consist of combustible cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton.

PM USA is the largest cigarette company in the United States and substantially all cigarettes are manufactured and sold to customers in the United States.

Middleton is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco. Middleton contracts with a third-party importer to supply substantially all of its cigars and sells substantially all of its cigars to customers in the United States.

Oral Tobacco Products Segment: Altria’s oral tobacco products consist of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix.

USSTC is the leading producer and marketer of MST products. The oral tobacco products segment includes the premium brands, Copenhagen and Skoal, and a value brand, Red Seal, sold by USSTC. In addition, the oral tobacco products segment includes on! oral nicotine pouches sold by Helix.

E-Vapor Products Segment: Altria’s e-vapor products segment includes electronic nicotine delivery systems (ENDS), commonly known as e-cigarettes or e-vapor products.

These products heat a liquid containing nicotine, flavorings, propylene glycol, vegetable glycerin, and other ingredients to produce an aerosol that users inhale1.

Unlike traditional cigarettes, e-vapor products do not involve combustion, which reduces exposure to harmful constituents found in cigarette smoke.

Altria participates in this segment through its wholly-owned subsidiary, NJOY, LLC, which offers products like NJOY ACE and NJOY Daily. These products have received marketing granted orders from the FDA for both tobacco and menthol variants.

All Other: Altria’s all other category included (i) the financial results of NJOY (beginning June 1, 2023); (ii) Horizon; (iii) Helix ROW; (iv) Altria’s former financial services business, which completed the wind-down of its portfolio of finance assets in 2022; and (v) the IQOS System heated tobacco business.

Back To Table Of Contents

Insight & Summary of Altria’s Segment Profit and Margin

Altria’s segment profitability shows two starkly different stories unfolding simultaneously — Smokeable Products has delivered consistent, expanding margins for a decade, while E-Vapor Products has become a source of dramatic, escalating losses that materially dragged down consolidated profitability in 2025.

• E-Vapor Products: A Rapidly Deteriorating Loss, Culminating in a Massive 2025 Decline This is the most significant finding in the entire dataset. E-Vapor Products OCI went from a modest -$16 million loss (2023) to -$171 million (2024) and then collapsed to -$2,297 million (2025) — an extraordinary deterioration that occurred even as E-Vapor revenue itself was small and turned negative (-$13 million) that same year. This -$2,297 million loss is by far the largest single-segment loss anywhere in the dataset, larger in magnitude than several other segments’ entire multi-year cumulative profits, and it’s the primary driver of Consolidated OCI’s decline from $11,856 million (2024) to just $10,286 million (2025) — a -13.2% drop in the company’s overall profitability metric.

• Smokeable Products: Consistent, Expanding Margins Throughout the Entire Period In sharp contrast to E-Vapor, Smokeable Products OCI Margin has expanded almost every year, from 46.8% (2016) to 63.0% (2025) — its highest level in the dataset — even as the segment’s underlying revenue has been declining in recent years (as established in prior analysis). This means Smokeable Products has become steadily more profitable on a per-dollar-of-revenue basis, a genuine and sustained margin-expansion story that has helped offset weakness elsewhere in the portfolio.

• Oral Tobacco Products: Strong But More Volatile Margins, With a Notable 2024 Dip Oral Tobacco Products OCI Margin has generally been the highest of any segment (peaking at 71.5% in 2020), but it’s also shown more year-to-year volatility than Smokeable Products, including a sharp drop to 54.2% (2024) before recovering to 67.6% (2025) — its second-highest level in the dataset. This 2024 margin dip, alongside Oral Tobacco Products OCI falling to $1,449 million that year (down from $1,722 million in 2023), stands out as a genuine one-year disruption rather than part of a longer trend, given the strong recovery the following year.

• Consolidated OCI Margin: A Sharp Reversal in 2025 After Years of Steady Improvement Consolidated OCI Margin climbed steadily from 46.6% (2016) to a peak of 60.1% (2023), before declining to 58.0% (2024) and then falling sharply to 51.1% (2025) — its lowest level since 2019. Given that both Smokeable Products and Oral Tobacco Products margins actually improved or stayed strong in 2025, this consolidated decline is attributable almost entirely to E-Vapor Products’ dramatic loss that year, illustrating how a small segment can meaningfully distort overall company profitability when its losses are large enough.

• Structural Takeaway: Altria’s segment profitability in 2025 reveals a genuine divergence: its two established, larger segments (Smokeable Products and Oral Tobacco Products) delivered strong or improving margins, while E-Vapor Products’ losses grew so severe that they single-handedly reversed several years of steady consolidated margin improvement. Given E-Vapor’s OCI has now deteriorated for three consecutive years with 2025’s loss dwarfing the prior two years combined, the trend worth monitoring going forward is whether this reflects a one-time, non-recurring charge (such as an asset impairment or write-down) or a genuinely worsening operating trajectory for the E-Vapor business — a distinction that will determine whether Consolidated OCI Margin snaps back toward its 2023 peak or continues to be weighed down by this smaller but increasingly costly segment.

The table below combines all key Altria’s segment OCI metrics into a single view for the latest three fiscal years.

Back To Table Of Contents

OCI breakdown by product category

Altria’s smokeable products segment primarily consists of cigarette and cigar sales. In contrast, notable brands in the oral tobacco product category include Copenhagen, Skoal, Red Seal, and on!.

The defintions of these segments are available here: smokeable products and oral tobacco products.

Altria’s OCI definition is available here: operating companies income.

Back To Table Of Contents

OCI margin by product category

Altria’s smokeable products segment primarily consists of cigarette and cigar sales. In contrast, notable brands in the oral tobacco product category include Copenhagen, Skoal, Red Seal, and on!.

The defintions of these segments are available here: smokeable products and oral tobacco products.

Altria’s OCI definition is available here: operating companies income.

Back To Table Of Contents

Revenue net of excise taxes by product category

Altria’s smokeable products segment primarily consists of cigarette and cigar sales. In contrast, notable brands in the oral tobacco product category include Copenhagen, Skoal, Red Seal, and on!.

The defintions of these segments are available here: smokeable products and oral tobacco products.

Altria’s OCI definition is available here: operating companies income.

Back To Table Of Contents

Credits And References

1. All financial data presented in this article was obtained and referenced from Altria’s annual reports published in the company’s investor relation page: Altria’s SEC Filings.

2. Pixabay Images.

Back To Table Of Contents

Disclosure

We may use artificial intelligence (AI) tools to assist us in writing some of the text in this article. However, the data is directly obtained from original sources (usually the quarterly and annual reports) and meticulously cross-checked by our editors multiple times to ensure its accuracy and reliability.

If you find the information in this article helpful, please consider sharing it on social media. Additionally, providing a link back to this article from any website can help us create more content like this in the future.

Thank you for your support and engagement! Your involvement helps us continue to provide high-quality, reliable content.

Back To Table Of Contents